N-Acetylaspartic acid
N-Acetylaspartic acid (NAA) is a derivative of aspartic acid with a role in the human body as a neurotransmitter and a source of acetyl groups. It is the second most prevalent neurotransmitter in the brain after glutamate. NAA is synthesized in neurons from aspartate and acetyl-CoA by the enzyme aspartate N-acetyltransferase and broken down by aspartoacylase into aspartate and acetyl-CoA in the oligodendrocytes.
Function[edit]
NAA functions as a molecular water pump, helping to remove water from neurons. This is crucial for maintaining the integrity of the myelin sheath, which insulates neurons and allows for efficient nerve impulse transmission. NAA also contributes to the production of acetylcholine, a neurotransmitter that plays a key role in memory and learning.
Clinical significance[edit]
Abnormal levels of NAA in the brain can indicate a variety of medical conditions. Decreased levels are often associated with conditions that cause damage or loss of neurons, such as Alzheimer's disease, multiple sclerosis, and stroke. Increased levels can indicate conditions that lead to an overproduction of NAA, such as Canavan disease, a rare inherited disorder that damages the ability of nerve cells in the brain to send and receive messages.
Research[edit]
Research into NAA is ongoing, with studies investigating its potential use as a biomarker for various neurological conditions. It is also being studied for its potential therapeutic uses, such as in the treatment of Canavan disease and other leukodystrophies.
See also[edit]
References[edit]
-
Acetylaspartate
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian